This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: University Health Network. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Justin Matthew Burgener: Innovator in Cancer Detection
Introduction
Justin Matthew Burgener is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of cancer detection through his innovative research and patented methodologies. His work focuses on improving the accuracy and efficiency of cancer diagnostics.
Latest Patents
Justin holds a patent for a groundbreaking method titled "Cancer detection and classification using methylome analysis." This patent describes a method of capturing cell-free methylated DNA from a sample containing less than 100 mg of cell-free DNA. The process involves several steps, including library preparation for sequencing, the addition of methylated filler DNA, denaturation of the sample, and the capture of cell-free methylated DNA using a selective binder for methylated polynucleotides. This innovative approach has the potential to enhance cancer detection and classification significantly.
Career Highlights
Justin is currently affiliated with the University Health Network, where he continues to advance his research in cancer diagnostics. His work is characterized by a commitment to improving patient outcomes through innovative technologies. He has successfully developed methods that could lead to earlier and more accurate cancer diagnoses.
Collaborations
Justin collaborates with esteemed colleagues in his field, including Scott Victor Bratman and Daniel Diniz De Carvalho. These partnerships enhance the research and development of new methodologies in cancer detection.
Conclusion
Justin Matthew Burgener is a pioneering inventor whose work in cancer detection is making a significant impact in the medical field. His innovative patent and ongoing research at the University Health Network highlight his dedication to improving cancer diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
